COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 1024: Articles 10231-10240  | Next

Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
Tanaka, T., Saito, A., Suzuki, T., Miyamoto, Y., Takayama, K., Okamoto, T., Moriishi, K.
10.1101/2021.12.23.474055 — Posted: 2021-12-25
Are COVID-19 data reliable? The case of the European Union
Kolias, P.
10.1101/2021.12.24.21268373 — Posted: 2021-12-25 Discussion: Onsite
Risk of myocarditis following sequential COVID-19 vaccinations by age and sex
Patone, M., Mei, W. X., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A., Channon, K. M., Mills, N. L., Sheikh, A., Hippisley-Cox, J.
10.1101/2021.12.23.21268276 — Posted: 2021-12-25 Discussion: Onsite
A novel methodology for the synchronous collection and multimodal visualisation of continuous neurocardiovascular and neuromuscular physiological data in adults with long COVID
Xue, F., Monaghan, A., Jennings, G., Byrne, L., Foran, T., Duggan, E., Romero-Ortuno, R.
10.1101/2021.12.24.21268370 — Posted: 2021-12-25
Genomic diversification of long polynucleotide fragments is a signature of emerging SARS-CoV-2 variants of concern
Murugadoss, K., Niesen, M. J., Raghunathan, B., Lenehan, P. J., Ghosh, P., Feener, T., Anand, P., Simsek, S., Suratekar, R., Hughes, T. K., Soundararajan, V.
10.1101/2021.12.23.21268315 — Posted: 2021-12-25 Discussion: Onsite
Influenza A H1N1 mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
Martin Almazan, N., Rahbar, A., Carlsson, M., Hoffman, T., Kolstad, L., Ronnberg, B., Russel Pantalone, M., Lewensohn Fuchs, I., Naucler, A., Ohlin, M., Sacharczuk, M., Religa, P., Amer, S., Molnar, C., Lundkvist, A., Susrud, A., Sorensen, B., Soderberg-Naucler, C.
10.1101/2021.12.23.21268321 — Posted: 2021-12-25 Discussion: Onsite
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
budhiraja, s., Indrayan, A., das, p., dewan, a., singh, o., nangia, v., singh, y. p., pandey, r., gupta, a. k., gupta, m., bhasin, d., uniyal, b., mathur, m., pawar, m.
10.1101/2021.12.24.21268371 — Posted: 2021-12-25
Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea
Kim, D., Jo, J., Lim, J.-S., Ryu, S.
10.1101/2021.12.25.21268301 — Posted: 2021-12-25
Genomic surveillance reveals the emergence of SARS-CoV-2 Lineage A from Islamabad Pakistan
Umair, M., Ikram, A., Rehman, Z., Haider, S. A., Badar, N., Ammar, M., Ali, Q., Ahad, A., Suleman, R., Salman, M.
10.1101/2021.12.24.21268367 — Posted: 2021-12-25
COMPARATIVE ANALYSIS OF ANTIBODY RESPONSES FROM COVID-19 CONVALESCENTS RECEIVING VARIOUS VACCINES REVEALS CONSISTENT HIGH NEUTRALIZING ACTIVITY FOR SARS-CoV-2 VARIANT OF CONCERN OMICRON.
Focosi, D. F., Franchini, M., Joyner, M. J., Casadevall, A.
10.1101/2021.12.24.21268317 — Posted: 2021-12-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).